523 results on '"Mertens, Koen"'
Search Results
152. Regions 301‒303 and 333‒339 in the catalytic domain of blood coagulation Factor IX are Factor VIII-interactive sites involved in stimulation of enzyme activity
153. Factor VIII-Factor IX Interactions: Molecular Sites Involved in Enzyme-Cofactor Complex Assembly
154. Utilization of Previously Treated Patients (PTPs), Noninfected Patients (NIPs), and Previously Untreated Patients (PUPs) in the Evaluation of New Factor VIII and Factor IX Concentrates
155. The Life Cycle of Coagulation Factor VIII in View of Its Structure and Function
156. A Human Alloantibody Interferes With Binding of Factor IXa to the Factor VIII Light Chain
157. Dissimilar interaction of factor VIII with endothelial cells and lipid vesicles during factor X activation
158. Ca2+ Binding to the First Epidermal Growth Factor-like Domain of Human Blood Coagulation Factor IX Promotes Enzyme Activity and Factor VIII Light Chain Binding
159. Kinetics of Factor VIII Light‐Chain Cleavage by Thrombin and Factor Xa
160. Enhanced Thrombin Sensitivity of a Factor VIII-Heparin Cofactor II Hybrid
161. The Sequence Glu1811-Lys1818 of Human Blood Coagulation Factor VIII Comprises a Binding Site for Activated Factor IX
162. Cleavage at Arginine 145 in Human Blood Coagulation Factor IX Converts the Zymogen into a Factor VIII Binding Enzyme
163. The Role of Cleavage of the Light Chain at Positions Arg1689 or Arg1721 in Subunit Interaction and Activation of Human Blood Coagulation Factor VIII
164. The activation of human blood coagulation factor X on the surface of endothelial cells: a comparison with various vascular cells, platelets and monocytes
165. Isolation and Characterization of Single-Chain Protein S
166. The optimal timing for imaging brain tumours and other brain lesions with 18F-labelled fluoromethylcholine.
167. Distribution Patterns of 18F-Labelled Fluoromethylcholine in Normal Structures and Tumors of the Head.
168. In Vitro2-Deoxy-2-[18F]Fluoro-D-Glucose Uptake: Practical Considerations.
169. 99mTc-Labeled Tricarbonyl His-CNA35 as an Imaging Agent for the Detection of Tumor Vasculature.
170. Storage of Factor VIII Variants with Impaired von Willebrand Factor Binding in Weibel-Palade Bodies in Endothelial Cells.
171. PET with 18F-labelled choline-based tracers for tumour imaging: a review of the literature.
172. Reduced dimethylaminoethanol in [18F]fluoromethylcholine: an important step towards enhanced tumour visualization.
173. Kinetics of angiogenic changes in a new mousemodel for hepatocellular carcinoma.
174. The Role of Factor VII in Haemostasis: Infusion Studies of Factor VIIa in a Canine Model of Factor VIII Deficiency
175. Sub-pixel mapping and sub-pixel sharpening using neural network predicted wavelet coefficients
176. A K-band SiGe bipolar VCO with transformer-coupled varactor for backhaul links.
177. Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease
178. Substitution of Arg[sup 527] and Arg[sup 531] in factor VIII associated with mild haemophilia A: characterization in terms of subunit interaction and cofactor function.
179. The optimal timing for imaging brain tumours and other brain lesions with 18F-labelled fluoromethylcholine
180. Thrombin-mediated activation of endogenous factor XI in plasma in the presence of physiological glycosaminoglycans occurs only with high concentrations of thrombin.
181. Factor VIII C1 domain residues Lys 2092 and Phe 2093 contribute to membrane binding and cofactor activity
182. Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older men
183. Intracellular cotrafficking of factor VIII and von Willebrand factor type 2N variants to storage organelles
184. Guanine exchange factor RalGDS mediates exocytosis of Weibel-Palade bodies from endothelial cells
185. Mechanisms of Disease: antiphospholipid antibodies—from clinical association to pathologic mechanism
186. Tolerance to factor VIII in a transgenic mouse expressing human factor VIII cDNA carrying an Arg593 to Cys substitution
187. LDL receptor cooperates with LDL receptor–related protein in regulating plasma levels of coagulation factor VIII in vivo
188. Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor–related protein deficiency
189. Optimizing the Dimensions of Driver and Power Transistor in Switching CMOS RF Amplifiers
190. Two classes of germline genes both derived from the VH1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII
191. 3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography
192. Functional mapping of anti–factor IX inhibitors developed in patients with severe hemophilia B
193. Multiple VH genes are used to assemble human antibodies directed toward the A3-C1 domains of factor VIII
194. Activation of factor IX zymogen results in exposure of a binding site for low-density lipoprotein receptor–related protein
195. Factor VIII-Factor IX Interactions: Molecular Sites Involved in Enzyme-Cofactor Complex Assembly
196. In-field detection of Alternaria solani in potato crops using hyperspectral imaging.
197. Ca2+Binding to the First Epidermal Growth Factor-like Domain of Human Blood Coagulation Factor IX Promotes Enzyme Activity and Factor VIII Light Chain Binding*
198. Blood Coagulation Factor IX Residues Glu78and Arg94Provide a Link between Both Epidermal Growth Factor-like Domains That Is Crucial in the Interaction with Factor VIII Light Chain*
199. On the Target Specificity of Plasminogen Activator Inhibitor 1: The Role of Heparin, Vitronectin, and the Reactive Site
200. Angiogenic changes in a new mouse model for hepatocellular carcinoma assessed with state-of-the-art imaging technology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.